Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS-related) | February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | May 7, 2025 (AIDS-related)

Funding Amounts: No budget cap; most projects expected ≤$250,000 direct costs/year for up to 5 years.

Summary: Supports development and validation of in vivo neurophysiological and behavioral assays in animals for early-phase therapeutic screening relevant to mental illnesses.

Key Information: Clinical trials are not allowed; human subject studies are not permitted under this opportunity.